The goal of this clinical trial is to test CRIS100 treatment in participants with acute thoracic spinal cord injury. The main questions it aims to answer are: * safety of CRIS100 * efficacy of CRIS100 Participants will receive 100 mcg CRIS100 in the epicenter of the spinal injury, within 72 hours of the trauma.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Serious adverse events (SAE)
Timeframe: 6 months
Anti-drug antibodies (ADA)
Timeframe: 6 months
Liver function
Timeframe: 6 months
Kidney function
Timeframe: 6 months
White blood cell (WBC)
Timeframe: 6 months
Hemoglobin
Timeframe: 6 months
Imaging exams
Timeframe: 6 months